ARTICLE | Company News
Immunomedics other research news
June 20, 1994 7:00 AM UTC
The National Cancer Institute granted the Morris Plains, N.J., company two SBIRs totalling $156,000 to develop antibody-drug conjugates and radioisotope-antibody conjugates. The goal of the first gran...